Literature DB >> 590637

Bone mass and bone density in maturity-type diabetics measured by the 125I photon-absorption technique.

I De Leeuw, R Abs.   

Abstract

Bone mineral content (BMC) and bone density (BMC/W) of the radius were measured in 138 maturity-type diabetics with the Norland-Cameron bone mineral analyzer and compared with the results of age- and sex-matched controls. In some age groups the mean cortical and trabecular bone mass and density seemed to be significantly higher among diabetic patients, especially in those treated with oral antidiabetic agents. Individual analysis reveals the existence of two distinct diabetic populations--a small group with a tendency to bone loss and a large group with bone gain--when compared with nondiabetic subjects. The higher body weight in the second group can be the origin of this difference. A survey of the already published papers on this subject shows that comparison of the results is impossible because of the heterogeneity in the methodology of material and methods used by the different authors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 590637     DOI: 10.2337/diab.26.12.1130

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  15 in total

1.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

2.  Bone mass in obese, goldthioglucose-treated, hyperglycaemic mice.

Authors:  I De Leeuw; P Van Rooy; M D'Hollander
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

3.  Evaluation of cortical bone mass, thickness and density by z-scores in osteopenic conditions and in relation to menopause and estrogen treatment.

Authors:  S Meema; H E Meema
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

4.  Osteoporosis: prevention and management strategies.

Authors:  S Evers; A Myers
Journal:  Can Fam Physician       Date:  1987-01       Impact factor: 3.275

5.  Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications.

Authors:  P Pietschmann; G Schernthaner; W Woloszczuk
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 6.  Glucagon-like peptide-1(GLP-1) receptor agonists: potential to reduce fracture risk in diabetic patients?

Authors:  Guojing Luo; Hong Liu; Hongyun Lu
Journal:  Br J Clin Pharmacol       Date:  2016-01       Impact factor: 4.335

7.  Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocin-induced diabetic rats: a quantitative autoradiographic study.

Authors:  T Sasaki; N S Ramamurthy; L M Golub
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

8.  Increasing serum osteocalcin after glycemic control in diabetic men.

Authors:  S Sayinalp; O Gedik; Z Koray
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

9.  Bone loss in diabetes: effects of metabolic state.

Authors:  P McNair; S Madsbad; C Christiansen; M S Christensen; O K Faber; C Binder; I Transbøl
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

10.  Abnormal cell calcium concentrations in cultured bone cells obtained from femurs of obese and noninsulin-dependent diabetic rats.

Authors:  J Levy; I Reid; L Halstad; J R Gavin; L V Avioli
Journal:  Calcif Tissue Int       Date:  1989-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.